Navigation Links
Gene Variant May Contribute to Alzheimer's Disease
Date:6/25/2008

ientists to test whether drugs will disrupt the effects of the genetic trait.

"This is a long process. We are really at the initial steps of design," he said. "If the original idea is good, usually people think it takes seven to 10 years to design a drug that will work in humans."

Dr. Sam Gandy, chairman of the Alzheimer's Association's National Medical and Scientific Advisory Council, said he was impressed by the quality of the new research, but he cautioned that similar kinds of findings have turned out to be "flashes in the pan."

The research "dovetails nicely" with existing knowledge regarding calcium and the degeneration of the brain, Gandy said. Ultimately, however, the true impact of the CALMH1 gene discovery will depend on future genetic research, he said.

In another development involving Alzheimer's research, scientists reported this week that studies with mice have helped them gain more knowledge into how a component of protein plaques appears to be directly related to the disease in some cases, but not in others.

The findings could help scientists gain greater understanding into why some people -- but not all -- who have plaques in brain tissue appear to have symptoms of the disease.

More information

Learn more about Alzheimer's from the Alzheimer's Association.



SOURCES: Philippe Marambaud, Ph.D., assistant professor of pathology, Albert Einstein College of Medicine, New York City; Sam Gandy, M.D., Ph.D., chair, National Medical and Scientific Advisory Council, Alzheimer's Association, and professor of Alzheimer's disease research, Mount Sinai School of Medicine, New York City; June 27, 2008, Cell


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
2. Scientists discover genetic variant associated with prostate cancer in African Americans
3. Gene Variant Doubles Risk of Prostate Cancer in Black Men
4. Gene Variant Tied to More Aggressive Prostate Cancer
5. Gene variant linked to moderated symptoms of beta-thalassemia
6. Gene variant predicts medication response in patients with alcohol dependence
7. Gene Variants Can Predict Threat of Heart Disease
8. Gene Variants Linked to Lung Cancer Identified
9. Gene Variant Protects Black Heart Failure Patients
10. Gene Variant Boosts Risk for Stress-Related Ischemia
11. Gene Variant Boosts Risk of Severe Diabetic Eye, Kidney Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Sierra Madre, CA (PRWEB) , ... June 30, ... ... held the company’s first UHMS approved 40-hour Introduction to Hyperbaric Medicine Course. Clinicians ... jam packed weekend of hyperbaric medicine curriculum. , Wound care and hyperbaric ...
(Date:6/30/2015)... ... June 30, 2015 , ... The LIV Fertility ... fertility preservation and deciding the right age to pursue egg freezing. Statistics show that ... age of 35 — a 150 percent increase since the 1970s. , Sadly, for ...
(Date:6/30/2015)... ... 30, 2015 , ... University Post-Acute Rehab recently released a ... rehab center’s patients and their experiences at the facility. Medicare granted University Post-Acute ... Each patient attests to the high rating, which is predominantly based on cleanliness, ...
(Date:6/30/2015)... ... June 30, 2015 , ... Lakeview Health, ... than doubled the size of its medical staff to further enhance its ability ... includes physicians, nurse practitioners and physician assistants -- now totals 17, compared to ...
(Date:6/30/2015)... ... June 30, 2015 , ... Rocky Mountain Oils, a leading ... management team and added a new CEO, Mr. Darold Francis. The changes will help ... premium essential oils that customers have come to know and respect for over eight ...
Breaking Medicine News(10 mins):Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 4Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 5Health News:Patients of University Post-Acute Rehab Support Five-Star Rating in New Video 2Health News:Lakeview Health, a Nationally Recognized Drug Rehabilitation Center in Florida, Doubles Size of Medical Staff 2Health News:Rocky Mountain Oils Adds New CEO, Announces Relocation of Operations to Orem, Utah 2
... would be helped by reauthorization of ... Program (SCHIP), WASHINGTON, Sept. 28 "We agree with ... who said, ,Covering,these children is worth every cent," said Dr. ... Hispanic Health, the nation,s leading,Hispanic health advocacy group. "The ...
... for All Children on October 6th, CAMBRIDGE, Mass., ... of Shire plc, the global specialty,biopharmaceutical company, invites families ... on Saturday, October 6th for,"Shire Day" when all children ... granted,free admission. As part of the day, all children ...
... for Easily Accessible, Patient- ... centered Facilities, CLEVELAND, ... officials, with the company of several public,officials including Senators Sherrod Brown ... of a 53-acre,field in Beachwood into a model showcase for 21st ...
... Church Team Up to Transport Goods to Peru, ... today,teamed up with its largest customer, DHL, to provide ... of Jesus Christ of Latter-day,Saints to help those injured ... Peru, on August 15, 2007. The 67,000 pounds of,specially ...
... The Russell,Investment Group has advised Protalix Biotherapeutics ... float weight adjustment effective after the close of,trading ... Russell 2000,Russell 2000 Growth, Russell 2500, Russell 2500 ... Growth, Russell Small Cap,Completeness and the Russell Small ...
... Immucor, Inc.,(Nasdaq: BLUD ), a global leader in ... announced that it expects,to release its first quarter earnings ... trading hours, and then host a conference call on,Thursday, ... the results. Investors,are invited to participate in this conference ...
Cached Medicine News:Health News:Hispanic Leaders Urge President Bush to Sign SCHIP Bill 2Health News:Families Invited to Celebrate 'Shire Day' at Boston Children's Museum 2Health News:UH to Break Ground for New Ahuja Medical Center 2Health News:UH to Break Ground for New Ahuja Medical Center 3Health News:ASTAR Air Cargo, The Church of Jesus Christ of Latter-day Saints and DHL to Help Peruvian Earthquake Victims 2Health News:ASTAR Air Cargo, The Church of Jesus Christ of Latter-day Saints and DHL to Help Peruvian Earthquake Victims 3Health News:Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment 2Health News:Immucor Schedules First Quarter Earnings Release and Conference Call 2
(Date:6/30/2015)... ATLANTA , June 30, 2015 Legal-Bay ... the first bellwether trial in the multidistrict litigation (MDL) ... scheduled to begin October 13 th , 2015. There ... Inc. which have been consolidated before a federal judge ... that the first bellwether trial will begin in October ...
(Date:6/29/2015)... , June 29, 2015  Daktari Diagnostics was honored at ... Technology in the Service of Society Award. IEEE President and ... Barry L. Shoop presented the award to Principal Scientist ... ceremony was held Saturday, June 20, 2015, at the historic ... . "I have spent more than 3 ...
(Date:6/29/2015)... Minn. , June 29, 2015 EnteroMedics ... of devices that use neuroblocking technology to treat obesity, ... it has commenced an underwritten public offering of units. ... stock, Series A warrants to purchase common stock and ... purchase of units in the offering would result in ...
Breaking Medicine Technology:Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 2Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 3Daktari Honored with IEEE Spectrum Award 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Proposed Public Offering of Common Stock and Warrants 3
... 5 P.M. EDT MONDAY, AUG. 4/, /ADVANCE/ ROCKVILLE, ... should not be,screened for prostate cancer, and younger men ... (PSA) test with their clinicians,before being tested, according to ... The recommendation and accompanying,evidence summary appear in the August ...
... 12 with 48-week boceprevir-based ... combination therapy ... KENILWORTH, N.J., Aug. 4 Schering-Plough,Corporation (NYSE: SGP ) today reported ... boceprevir, its investigational,oral hepatitis C protease inhibitor. The analysis showed a high ...
Cached Medicine Technology:Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer 2Task Force Says Men Age 75 and Older Should Not Be Screened For Prostate Cancer 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 2Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 3Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 4Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 5Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 6Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 7Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 8Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients 9
... scaleable device that works with ... plasma or buffy coat. The ... must be prepared independently using ... volume and concentration factor can ...
Avitene Microfibrillar Collagen (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
The Ultrafoam Collagen Sponge is indicated in all surgical procedures as an adjunct to hemostasis when control by ligature or conventional procedures are ineffective or impractical....
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Medicine Products: